ID1 and ovarian carcinoma: We demonstrate for the first time that promotion of autophagy by both pharmacological and non-pharmacological strategies leads to proteolytic degradation of ID1 in the CSC-enriched side population (SP) of platinum-resistant epithelial ovarian cancer (EOC) cell lines.